Medivir AB (publ) (LON:0GP7)
1.950
0.00 (0.00%)
At close: Sep 3, 2025
Medivir AB Revenue
Medivir AB had revenue of 1.50M SEK in the quarter ending June 30, 2025, with 36.36% growth. This brings the company's revenue in the last twelve months to 3.98M, down -42.54% year-over-year. In the year 2024, Medivir AB had annual revenue of 3.48M, down -54.36%.
Revenue (ttm)
3.98M SEK
Revenue Growth
-42.54%
P/S Ratio
56.07
Revenue / Employee
398.40K SEK
Employees
10
Market Cap
17.15M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.48M | -4.15M | -54.36% |
Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
Dec 31, 2020 | 20.43M | 11.71M | 134.18% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |